Importantly, the morphological aspect and lack of immunoreactivity for GFAP and SMA within the tumor itself helps rule out gliomas, meningiomas, or smooth muscle tumors as differential diagnoses41,42. The gene discussed is SMN1; the disease is smooth muscle tumor.